A symposium on how to handle regulation in the post-Trump era
OIRA
Posted inDay One Agenda
OIRA 2.0: Using OIRA for Progressive Regulation
OIRA should be modernized to support a robust regulatory agenda.
Posted inDay One Agenda
It’s Time for OIRA to Go
No amount of reform can rehabilitate an agency designed to subvert progressive goals.
Posted inDay One Agenda
Why Bolster the Regulatory Gatekeeper?
The coronavirus pandemic makes it more urgent to get the regulatory state right. An expanded OIRA assisting this effort is vital.
Posted inDay One Agenda
The Big Misstep in a Worthwhile OIRA 2.0 Proposal
The Tucker and Nayak paper fails to recognize cost-benefit analysis as a political weapon.
Posted inDay One Agenda
Rethinking OIRA: Laying the Groundwork for a Progressive Presidency
The agency currently works to slow down and stop regulatory action. It could be put to use to accelerate it.
Posted inHealth and Social Policy
Big Tobacco Lobbied to Save Vaping. Now It Controls the Leading E-Cigarette Company.
Altria lobbying helped strike down a ban on flavored vaping liquids. Later it bought into Juul.
Posted inDay One Agenda
The Little Agency That Could (Block All Good Regulations)
The Day One agenda is dependent on the functions of OIRA, an obscure federal agency that acts as a bottleneck for agency rules and regulations.
